Is multiple myeloma painful?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Is Multiple Myeloma Painful?

Yes, multiple myeloma is commonly associated with significant pain, particularly bone pain, which affects approximately 80% of patients due to osteolytic lesions and vertebral compression fractures. 1

Causes of Pain in Multiple Myeloma

Multiple myeloma causes pain through several mechanisms:

  1. Bone Destruction

    • Osteolytic lesions (bone destruction) are present in up to 80% of patients at diagnosis 1
    • These lesions weaken bones and lead to skeletal-related events (SREs)
    • Pain occurs due to:
      • Bone destruction from increased osteoclastic activity
      • Decreased osteoblastic function (reduced bone formation)
  2. Vertebral Compression Fractures

    • Almost 80% of patients with vertebral compression fractures experience pain that is often non-responsive to standard pain medications 1
    • These fractures can cause severe, debilitating pain and mobility issues
  3. Pathological Fractures

    • Long bone fractures cause acute, severe pain
    • Require surgical intervention for stabilization
  4. Spinal Cord Compression

    • Extremely painful and can lead to neurological deficits
    • Considered a medical emergency

Management of Pain in Multiple Myeloma

Anti-Myeloma Therapy

Treating the underlying disease is fundamental to pain management, as effective control of myeloma can reduce bone destruction.

Bone-Targeted Therapies

  1. Bisphosphonates (BPs)

    • First-line treatment for bone disease in myeloma 1
    • Zoledronic acid or pamidronate should be given to patients with adequate renal function and bone disease 1
    • Dosing considerations:
      • For patients with CrCl 30-60 mL/min: reduced doses of zoledronic acid or pamidronate via 4-hour infusion 1
      • Avoid in patients with CrCl <30 mL/min 1
  2. Denosumab

    • Alternative for patients with renal impairment
    • Currently indicated for resistant hypercalcemia to BPs 1

Interventional Approaches

  1. Radiotherapy

    • Indicated for extremely painful lytic lesions 1
    • Typical dose: 3000 cGy in 10-15 fractions 1
    • Provides effective pain relief but may delay systemic anti-myeloma therapies
  2. Balloon Kyphoplasty/Vertebroplasty

    • Treatment of choice for painful vertebral compression fractures 1
    • Nearly 80% of patients experience pain relief when conventional pain management fails 1
    • Kyphoplasty is preferred due to lower rates of cement leakage (Grade 1A evidence) 1
  3. Surgery

    • Indicated for:
      • Fixing pathological fractures of long bones
      • Stabilizing unstable spinal fractures
      • Spinal cord compression with bone fragments 1

Pain Management Algorithm

For pain control, a stepwise approach is recommended:

  1. Mild Pain

    • Paracetamol/acetaminophen (up to 1g four times daily) 1
    • Avoid NSAIDs due to potential renal complications (Grade 2C) 1
  2. Moderate Pain

    • Oral tramadol or codeine 1
    • Consider adjuvant medications
  3. Severe Chronic Pain

    • Fentanyl or buprenorphine patches
    • Oxycodone 1
    • Always provide laxatives with opioids (Grade 1A) 1
  4. Acute Severe Pain

    • Subcutaneous opioid injections (oxycodone or morphine) for rapid relief 1
  5. Adjuvant Medications

    • Calcium channel blockers (gabapentin, pregabalin)
    • Sodium channel blockers (lidocaine, oxcarbazepine)
    • Serotonin-norepinephrine reuptake inhibitors (duloxetine, amitriptyline) 1

Common Pitfalls and Caveats

  1. Renal Function Monitoring

    • Essential when using bisphosphonates
    • Measure CrCl before each infusion 1
    • Discontinue if renal function deteriorates until CrCl returns to within 10% of baseline 1
  2. Dental Health

    • Thorough dental examination before bisphosphonate therapy
    • Resolve major dental problems before starting treatment 1
    • Risk of osteonecrosis of the jaw with bisphosphonates 2
  3. Pain Assessment

    • Regular assessment of pain intensity and character is crucial
    • Differentiate between nociceptive and neuropathic pain components
    • Consider treatment-related pain (e.g., chemotherapy-induced peripheral neuropathy)
  4. Balancing Pain Control and Side Effects

    • Monitor for opioid-related adverse effects
    • Some patients may experience severe bone pain after bisphosphonate infusion 2

Multiple myeloma pain management requires a comprehensive approach that addresses both the underlying disease and provides symptomatic relief. Early intervention with appropriate bone-targeted therapies and analgesics can significantly improve quality of life for patients with this painful condition.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.